Episode
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Published
- Apr 3, 2026
- Duration seconds
- 1330
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/immunotherapy-and-targeted-therapy-for-advanced-gastroesophageal-cancers-microlearning-activity-2-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gi-cancers-symposium/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/immunotherapy-and-targeted-therapy-for-advanced-gastroesophageal-cancers-microlearning-activity-2-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gi-cancers-symposium.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Samuel Klempner from Massachusetts General Hospital in Boston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, and Dr John Strickler from Duke University in Durham, North Carolina, review relevant data supporting immunotherapy for patients with gastroesophageal cancers and recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here .